Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net income (loss)	$ 4,254	$ 2,498	$ 1,630
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	672	634	557
Amortization of debt issuance costs, premium and discount	28	30	29
Loss on modification or extinguishment of debt	6	33	101
Total losses (gains) on derivative instruments, net	(2,082)	1,158	(29)
Total gains on derivatives instruments, net—related party	0	0	(2)
Net cash used for settlement of derivative instruments	(2)	(102)	(17)
Other	20	44	27
Changes in operating assets and liabilities:
Trade and other receivables, net of current expected credit losses	254	(112)	(204)
Trade receivables—affiliate	273	(335)	(32)
Accounts receivable—related party	0	0	(1)
Advances to affiliate	85	(36)	2
Inventory	18	12	(68)
Margin deposits	35	(28)	(3)
Accounts payable and accrued liabilities	(467)	354	321
Accrued liabilities—related party	(2)	3	(1)
Due to affiliates	(18)	20	1
Total deferred revenue	46	(11)	18
Other, net	(11)	(24)	(38)
Other, net—affiliate	0	11	0
Net cash provided by operating activities	3,109	4,149	2,291
Cash flows from investing activities
Property, plant and equipment, net	(220)	(451)	(648)
Other	(7)	0	0
Net cash used in investing activities	(227)	(451)	(648)
Cash flows from financing activities
Proceeds from issuances of debt	1,397	559	3,182
Redemptions and repayments of debt	(1,700)	(1,560)	(3,600)
Distributions	(2,907)	(2,635)	(1,451)
Other	(37)	(40)	(107)
Net cash used in financing activities	(3,247)	(3,676)	(1,976)
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents	(365)	22	(333)
Cash, Cash Equivalents—beginning of period	996	974	1,307
Cash, Cash Equivalents—end of period	$ 631	$ 996	$ 974